PHARMACEUTICAL INDUSTRY COULD BE WIN REAL GLOBAL FREE TRADE AS WTO’S DOHA ROUND DRAWS TO A CLOSE

BY KEITH NUTHALL WITH the World Trade Organisation's (WTO) seven-year-old Doha Development Round maybe drawing towards a close, the pharmaceutical industry might start to consider that a final deal could lead to the elimination of most import duties on drugs and medicines, traded worldwide. That is the ambition of a two special sectoral negotiations within the round's market access for non-agricultural products (or NAMA) talks - one for 'open access to enhanced healthcare (pharmaceuticals and medical devices)' and the other for 'chemical products', which could ...


Full access to this article can be arranged with permission from the client that first ordered it. Please contact us to request access. Entries are uploaded to our archive at least one year after being published by a client – free access is restricted to International News Services journalists for background research only. The article date indicates when copy was filed to a client, not when posted to this archive. Upon client requests, International News Services will remove such articles from the archive or not upload them in the first place. They are included to demonstrate the breadth of topics undertaken by the agency and also to help promote clients’ coverage.